Literature DB >> 3831026

The reliability of the tracing-method of fine cardiac fibrosis at a magnification of x10--preliminary study for quantitative analysis of fibrosis in large tissue sections of hearts with cardiomyopathy.

H Fujiwara, T Onodera, M Tanaka, T Fujiwara, C Kawai, Y Hamashima.   

Abstract

to define the reliability of the tracing method of fine fibrosis at low magnification (x10), the percentage area of fine fibrosis was compared between the traced pictures at magnifications of x10 and x250, using an image analyzer (Olympus VIP-21). A total of 25 tissue areas, each approximately 4 x 7 mm, from the inner and middle thirds of the left ventricular free wall and ventricular septum were selected from ten hearts with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) and were stained with Masson trichrome. The percentage areas of fine fibrosis traced at a magnification of x10 correlated well with those traced at a magnification of x250 (Y = 1.08X - 1.1, r = 0.95, P less than 0.01). It is concluded that the overall percentage area of fibrosis is the same at magnifications of x10 and x250, despite the fact that at x10 one is unable to detect individual fibers which can be detected at x250. The tracing method of fine cardiac fibrosis at a magnification of x10 is reliable. Therefore, fine fibrosis in large tissue sections of hearts with cardiomyopathy, such as entire transverse sections of the left ventricular wall, can be quantitatively analyzed by this method.

Entities:  

Mesh:

Year:  1985        PMID: 3831026     DOI: 10.1007/bf02066416

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  6 in total

1.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W C Roberts
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

2.  Classification and distribution of myocardial fascicle and fiber disarray in 14 hearts with hypertrophic cardiomyopathy in 25 mu thick sections.

Authors:  H Fujiwara; T Hoshino; T Fujiwara; C Kawai; Y Hamashima
Journal:  Jpn Circ J       Date:  1982-03

3.  Number and size of myocytes and amount of interstitial space in the ventricular septum and in the left ventricular free wall in hypertrophic cardiomyopathy.

Authors:  H Fujiwara; T Hoshino; K Yamana; T Fujiwara; M Furuta; Y Hamashima; C Kawai
Journal:  Am J Cardiol       Date:  1983-10-01       Impact factor: 2.778

4.  Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

Authors:  M G St John Sutton; J T Lie; K R Anderson; P C O'Brien; R L Frye
Journal:  Br Heart J       Date:  1980-10

5.  Human myocardial histologic characteristics in congestive heart failure.

Authors:  D V Unverferth; J K Fetters; B J Unverferth; C V Leier; R D Magorien; A R Arn; P B Baker
Journal:  Circulation       Date:  1983-12       Impact factor: 29.690

6.  Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy.

Authors:  F Schwarz; G Mall; H Zebe; J Blickle; H Derks; J Manthey; W Kübler
Journal:  Am J Cardiol       Date:  1983-02       Impact factor: 2.778

  6 in total
  3 in total

1.  Three-dimensional distribution of myocardial fibrosis in the new J-2-N cardiomyopathic hamster: comparison with electrocardiographic findings.

Authors:  A Takeda; S Kawai; R Okada; M Nagai; N Takeda; M Nagano
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

2.  Quantitative analysis of myocardial infarction in (NZW x BXSB)F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease.

Authors:  H Yoshida; H Fujiwara; T Fujiwara; S Ikehara; Y Hamashima
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

3.  Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy.

Authors:  M Tanaka; H Fujiwara; T Onodera; D J Wu; Y Hamashima; C Kawai
Journal:  Br Heart J       Date:  1986-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.